AAV-based shRNA silencing of NF-κB ameliorates muscle pathologies in mdx mice
- PMID: 22278411
- DOI: 10.1038/gt.2011.207
AAV-based shRNA silencing of NF-κB ameliorates muscle pathologies in mdx mice
Abstract
Chronic inflammation, promoted by an upregulated NF-kappa B (NF-κB) pathway, has a key role in Duchenne muscular dystrophy (DMD) patients' pathogenesis. Blocking the NF-κB pathway has been shown to be a viable approach to diminish chronic inflammation and necrosis in the dystrophin-defective mdx mouse, a murine DMD model. In this study, we used the recombinant adeno-associated virus serotype 9 (AAV9) carrying an short hairpin RNA (shRNA) specifically targeting the messenger RNA of NF-κB/p65 (p65-shRNA), the major subunit of NF-κB associated with chronic inflammation in mdx mice. We examined whether i.m. AAV9-mediated delivery of p65-shRNA could decrease NF-κB activation, allowing for amelioration of muscle pathologies in 1- and 4-month-old mdx mice. At 1 month after treatment, NF-κB/p65 levels were significantly decreased by AAV gene transfer of p65-shRNA in the two ages of treatment groups, with necrosis significantly decreased compared with controls. Quantitative analysis revealed that central nucleation (CN) of the myofibers of p65-shRNA-treated 1-month-old mdx muscles was reduced from 67 to 34%, but the level of CN was not significantly decreased in treated 4-month-old mdx mice. Moreover, delivery of the p65-shRNA enhanced the capacity of myofiber regeneration in old mdx mice treated at 4 months of age when the dystrophic myofibers were most exhausted; however, such p65 silencing diminished the myofiber regeneration in young mdx mice treated at 1 month of age. Taken together, these findings demonstrate that the AAV-mediated delivery of p65-shRNA has the capacity to ameliorate muscle pathologies in mdx mice by selectively reducing NF-κB/p65 activity.
Similar articles
-
Inhibition of the IKK/NF-κB pathway by AAV gene transfer improves muscle regeneration in older mdx mice.Gene Ther. 2010 Dec;17(12):1476-83. doi: 10.1038/gt.2010.110. Epub 2010 Aug 19. Gene Ther. 2010. PMID: 20720575 Free PMC article.
-
Genetic ablation of P65 subunit of NF-κB in mdx mice to improve muscle physiological function.Muscle Nerve. 2017 Oct;56(4):759-767. doi: 10.1002/mus.25517. Epub 2017 May 15. Muscle Nerve. 2017. PMID: 27997693
-
Effect of nuclear factor κB inhibition on serotype 9 adeno-associated viral (AAV9) minidystrophin gene transfer to the mdx mouse.Mol Med. 2012 May 9;18(1):466-76. doi: 10.2119/molmed.2011.00404. Mol Med. 2012. PMID: 22231732 Free PMC article.
-
Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).Gene Ther. 2004 Oct;11 Suppl 1:S109-21. doi: 10.1038/sj.gt.3302379. Gene Ther. 2004. PMID: 15454965 Review.
-
AAV Delivery of Endothelin-1 shRNA Attenuates Cold-Induced Hypertension.Hum Gene Ther. 2017 Feb;28(2):190-199. doi: 10.1089/hum.2016.047. Epub 2016 Oct 11. Hum Gene Ther. 2017. PMID: 27736201 Free PMC article. Review.
Cited by
-
Exercise-activated hepatic autophagy via the FN1-α5β1 integrin pathway drives metabolic benefits of exercise.Cell Metab. 2023 Apr 4;35(4):620-632.e5. doi: 10.1016/j.cmet.2023.01.011. Epub 2023 Feb 21. Cell Metab. 2023. PMID: 36812915 Free PMC article.
-
Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.ILAR J. 2014;55(1):119-49. doi: 10.1093/ilar/ilu011. ILAR J. 2014. PMID: 24936034 Free PMC article. Review.
-
NF-κB inhibition rescues cardiac function by remodeling calcium genes in a Duchenne muscular dystrophy model.Nat Commun. 2018 Aug 24;9(1):3431. doi: 10.1038/s41467-018-05910-1. Nat Commun. 2018. PMID: 30143619 Free PMC article.
-
Endogenous MicroRNA Competition as a Mechanism of shRNA-Induced Cardiotoxicity.Mol Ther Nucleic Acids. 2020 Mar 6;19:572-580. doi: 10.1016/j.omtn.2019.12.007. Epub 2019 Dec 18. Mol Ther Nucleic Acids. 2020. PMID: 31927330 Free PMC article.
-
A designer polyQ fusion protein modulates NF-κB signaling by sequestering P65/RelA into aggregates.Sci Rep. 2025 Jul 27;15(1):27351. doi: 10.1038/s41598-025-13237-3. Sci Rep. 2025. PMID: 40717130 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources